Elizabeth Phillips to Risk Assessment
This is a "connection" page, showing publications Elizabeth Phillips has written about Risk Assessment.
Connection Strength
0.063
-
NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS. Trans Am Clin Climatol Assoc. 2018; 129:74-87.
Score: 0.032
-
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Sci Rep. 2017 08 17; 7(1):8653.
Score: 0.031